2023-03-30T16:58:22+08:00 weekly 1.0 https://mt.prisysbiotech.com/ 2024-11-11T06:19:56+08:00 weekly 0.9 https://mt.prisysbiotech.com/metabolic-syndromes-research 2024-11-11T06:19:49+08:00 weekly 0.9 https://mt.prisysbiotech.com/respiratory-disease-research 2024-11-11T06:19:35+08:00 weekly 0.9 https://mt.prisysbiotech.com/animal-welfare 2024-11-11T06:19:33+08:00 weekly 0.9 https://mt.prisysbiotech.com/translational-research-center 2024-11-11T06:20:03+08:00 weekly 0.9 https://mt.prisysbiotech.com/cns-disorders-behavior-analysis 2023-02-27T15:56:40+08:00 weekly 0.9 https://mt.prisysbiotech.com/co-develop 2024-11-11T06:19:48+08:00 weekly 0.9 https://mt.prisysbiotech.com/ophthalmic-disease-research 2024-11-11T06:19:36+08:00 weekly 0.9 https://mt.prisysbiotech.com/hematological-disease-research 2024-11-11T06:19:38+08:00 weekly 0.9 https://mt.prisysbiotech.com/inflammation-immunology-disorders 2026-08-08T13:26:17+08:00 weekly 0.9 https://mt.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://mt.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://mt.prisysbiotech.com/fibrosis 2024-11-11T06:19:33+08:00 weekly 0.9 https://mt.prisysbiotech.com/about-us 2024-11-11T06:19:33+08:00 weekly 0.9 https://mt.prisysbiotech.com/contact-us 2023-04-01T14:45:43+08:00 weekly 0.9 https://mt.prisysbiotech.com/newslist-1 2024-11-11T06:19:31+08:00 weekly 0.9 https://mt.prisysbiotech.com/products 2023-04-01T14:14:56+08:00 weekly 0.9 https://mt.prisysbiotech.com/safety-evaluation/ 2023-04-01T14:14:56+08:00 weekly 0.9 https://mt.prisysbiotech.com/translation-research/ 2023-04-01T14:14:56+08:00 weekly 0.9 https://mt.prisysbiotech.com/pk-pd-adme/ 2023-04-01T14:14:56+08:00 weekly 1.0 https://mt.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T14:14:56+08:00 weekly 0.9 https://mt.prisysbiotech.com/biosafety-research/ 2024-04-10T00:23:29+08:00 weekly 0.9 https://mt.prisysbiotech.com/clearpoint/ 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-11T06:19:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-11T06:19:32+08:00 weekly 0.8 https://mt.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-11T06:20:15+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2026-08-13T16:29:08+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-11T06:19:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-11T06:19:36+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-11T06:19:28+08:00 weekly 0.8 https://mt.prisysbiotech.com/translation-research/nhpresources.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-11T06:19:37+08:00 weekly 0.8 https://mt.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-11T06:19:50+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-11T06:19:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-11T06:19:33+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-11T06:19:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-11T06:19:33+08:00 weekly 0.8 https://mt.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-11T06:19:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/translation-research/translational-studies.html 2024-11-11T06:19:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-11T06:19:36+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-11T06:19:32+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2026-08-13T16:29:17+08:00 weekly 0.8 https://mt.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-11T06:19:40+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-11T06:19:40+08:00 weekly 0.8 https://mt.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-11T06:19:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-11T06:19:35+08:00 weekly 0.8 https://mt.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-11T06:19:47+08:00 weekly 0.8 https://mt.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-11T06:19:28+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-11T06:19:40+08:00 weekly 0.8 https://mt.prisysbiotech.com/translation-research/clinical-imaging.html 2024-10-05T17:20:08+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-10-05T17:20:10+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-10-05T17:20:10+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-11T06:19:46+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-10-05T17:20:11+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-10-05T17:20:11+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-10-05T17:41:39+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-12-07T17:30:36+08:00 weekly 0.8 https://mt.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-07T17:34:14+08:00 weekly 0.8 https://mt.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-04-01T22:26:11+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-01T22:26:15+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-25T06:25:24+08:00 weekly 0.8 https://mt.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-07-25T07:04:17+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-08-26T04:35:17+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-16T04:26:14+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-23T16:26:53+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-10-01T13:12:59+08:00 weekly 0.8 https://mt.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-07T07:23:21+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T20:32:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T23:28:12+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-04-29T10:31:27+08:00 weekly 0.8 https://mt.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-04-29T10:31:30+08:00 weekly 0.8 https://mt.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-04-29T10:31:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-04-29T10:31:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-25T18:18:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2026-05-25T18:18:37+08:00 weekly 0.8 https://mt.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2023-04-01T14:14:55+08:00 weekly 0.9 https://mt.prisysbiotech.com/newslist-714518-1 2023-04-01T14:14:56+08:00 weekly 0.9 https://mt.prisysbiotech.com/newslist-714519-1 2024-08-03T14:47:11+08:00 weekly 0.9 https://mt.prisysbiotech.com/newslist-820043-1 2026-04-29T10:31:13+08:00 weekly 0.9 https://mt.prisysbiotech.com/newslist-17851041263739904-1 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/meetprisys-sot2023-66147908.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66147909.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66147910.html 2026-09-01T20:36:54+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66147912.html 2026-09-01T20:36:53+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66147913.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-sot2023-66147914.html 2026-09-01T20:36:53+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/gene-therapy-nhp-model-66147915.html 2026-09-01T20:36:57+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66147916.html 2026-09-01T20:36:52+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66148627.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66148628.html 2026-09-01T20:36:37+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/gene-therapy-toxicology-66275777.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/world-parkinsons-disease-day-67577675.html 2026-09-01T20:36:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67578407.html 2026-09-01T20:36:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67579556.html 2026-09-01T20:36:36+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67580369.html 2026-09-01T20:36:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67580370.html 2026-09-01T20:36:48+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67585712.html 2026-09-01T20:36:35+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67590986.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67600449.html 2026-09-01T20:36:35+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68132344.html 2026-09-01T20:29:52+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68132352.html 2026-09-01T20:36:35+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68132357.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68132365.html 2026-09-01T20:29:51+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306048.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69074591.html 2026-09-01T20:29:55+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69075031.html 2026-09-01T20:29:58+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69075267.html 2026-09-01T20:30:09+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69075270.html 2026-09-01T20:29:54+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69076467.html 2026-09-01T20:29:57+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69076470.html 2026-09-01T20:36:36+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309291.html 2026-09-01T20:36:39+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309327.html 2026-09-01T20:29:57+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309328.html 2026-09-01T20:29:59+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309420.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69667791.html 2026-07-21T04:26:50+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69667793.html 2026-09-01T20:29:54+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71026985.html 2026-09-01T20:29:59+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71026986.html 2026-09-01T20:29:56+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71026987.html 2026-09-01T20:30:03+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71027236.html 2026-09-01T20:30:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/0-71027474.html 2026-09-01T20:29:55+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71028180.html 2026-09-01T20:29:58+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72337882.html 2026-09-01T20:30:00+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72337883.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72337884.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72337885.html 2026-09-01T20:30:01+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72337887.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72716978.html 2026-09-01T20:36:43+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73034605.html 2026-09-01T20:36:37+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73859525.html 2026-09-01T20:36:36+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73860572.html 2026-07-21T04:26:55+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74277662.html 2026-09-01T20:36:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74710611.html 2026-09-01T20:36:39+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74822401.html 2026-09-01T20:30:07+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75179978.html 2026-09-01T20:30:21+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75179981.html 2026-09-01T20:36:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76263127.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77126539.html 2026-09-01T20:30:12+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77818721.html 2024-11-11T06:19:29+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77818722.html 2026-09-01T20:30:04+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-asthma-model-79208802.html 2026-09-01T20:30:00+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79208803.html 2026-09-01T20:30:02+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79208806.html 2026-09-01T20:30:03+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79208810.html 2026-09-01T20:30:03+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79208827.html 2026-09-01T20:30:02+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79561514.html 2024-11-11T06:19:32+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79561515.html 2026-09-01T20:30:02+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79561516.html 2026-09-01T20:30:03+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79573869.html 2026-09-01T20:36:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pk-strategies-of-pdc-79573871.html 2026-09-01T20:30:04+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79573872.html 2026-09-01T20:36:42+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79573873.html 2026-09-01T20:36:43+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79573874.html 2026-09-01T20:30:05+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79573875.html 2026-09-01T20:30:05+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79573876.html 2026-09-01T20:36:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79573877.html 2026-09-01T20:30:09+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79573878.html 2026-09-01T20:30:07+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79573879.html 2026-09-01T20:30:05+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79573880.html 2026-09-01T20:30:15+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79573881.html 2026-09-01T20:30:08+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79573882.html 2026-09-01T20:30:07+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79573883.html 2026-09-01T20:30:21+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79573884.html 2026-09-01T20:30:07+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79573885.html 2026-09-01T20:30:10+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79573886.html 2026-09-01T20:30:09+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79573887.html 2026-09-01T20:30:08+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79573888.html 2026-09-01T20:30:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79573889.html 2026-09-01T20:36:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79573890.html 2026-09-01T20:36:44+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79573891.html 2026-09-01T20:30:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79573892.html 2026-09-01T20:30:10+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79573893.html 2026-09-01T20:36:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79573894.html 2026-09-01T20:30:14+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79573895.html 2026-09-01T20:30:22+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79573896.html 2026-09-01T20:30:17+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79573897.html 2026-09-01T20:30:16+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79573898.html 2026-09-01T20:30:22+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79573899.html 2026-09-01T20:30:13+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79573900.html 2026-09-01T20:30:21+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79573901.html 2026-09-01T20:30:12+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79573902.html 2026-09-01T20:30:22+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79573903.html 2026-09-01T20:36:42+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79573904.html 2026-09-01T20:30:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79573905.html 2026-09-01T20:36:42+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79573906.html 2026-09-01T20:30:24+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79573907.html 2026-09-01T20:36:42+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79573909.html 2026-09-01T20:36:48+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/mrna-based-therapies-past-79573910.html 2026-09-01T20:30:45+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/mrna-based-therapies-present-79573911.html 2026-09-01T20:30:33+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79573912.html 2026-09-01T20:36:48+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79573913.html 2026-09-01T20:36:48+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79573914.html 2026-09-01T20:30:07+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79573915.html 2026-09-01T20:36:43+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79573916.html 2026-09-01T20:30:14+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/significance-principles-and-requirements-of-79573917.html 2026-09-01T20:36:50+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656502.html 2026-09-01T20:36:49+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81334100.html 2026-09-01T20:36:12+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81334101.html 2026-09-01T20:36:51+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81334102.html 2026-09-01T20:36:21+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/human-disease-animal-models-81334103.html 2026-09-01T20:36:50+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/convection-enhanced-delivery-81334104.html 2026-09-01T20:36:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81334105.html 2026-09-01T20:36:32+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/animal-models-of-human-diseases-81334106.html 2026-09-01T20:36:36+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/china-experimental-monkey-industry-81334107.html 2026-09-01T20:36:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81334111.html 2026-09-01T20:36:32+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81334112.html 2026-09-01T20:36:47+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81334113.html 2026-09-01T20:36:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81334307.html 2026-09-01T20:31:14+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/compartment-pk-model-81334309.html 2026-09-01T20:36:27+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82311243.html 2026-09-01T20:36:26+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82760406.html 2026-09-01T20:36:26+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82760407.html 2026-09-01T20:36:28+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82760409.html 2026-09-01T20:36:26+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82760410.html 2026-09-01T20:36:49+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82760411.html 2026-09-01T20:36:30+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82760417.html 2026-09-01T20:36:26+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82760711.html 2026-09-01T20:36:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82760712.html 2026-09-01T20:36:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82760713.html 2026-09-01T20:36:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83025293.html 2026-09-01T20:36:32+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83028994.html 2026-09-01T20:36:33+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83029267.html 2026-09-01T20:36:37+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83992071.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83992072.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83992073.html 2026-09-01T20:36:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83992074.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83992077.html 2026-09-01T20:36:50+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83992104.html 2026-09-01T20:36:33+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83992139.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83992149.html 2026-09-01T20:36:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83993186.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243517355140096.html 2026-09-01T20:36:52+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243517646513152.html 2026-09-01T20:36:37+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/animal-models-for-womens-health-17295434685752320.html 2026-09-01T20:36:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295434736362496.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295434751747072.html 2026-07-21T04:27:18+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295434765444096.html 2026-07-21T04:27:15+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/membranous-nephropathy-model-17295434774569984.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295434804241408.html 2026-09-01T20:36:29+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295434842072064.html 2026-09-01T20:36:32+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295434880148480.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295434933363712.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295434996638720.html 2026-09-01T20:36:45+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295435086062592.html 2026-07-21T04:28:05+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295435110622208.html 2026-09-01T20:37:16+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295435162739712.html 2026-07-21T04:27:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295435207975936.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295435242939392.html 2026-09-01T20:36:45+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295459799081984.html 2026-07-21T04:27:50+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298957669639168.html 2026-07-21T04:29:06+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374216436491264.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374216499848192.html 2026-07-21T04:27:28+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374216517985280.html 2026-09-01T20:36:29+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374216528749568.html 2026-07-21T04:50:14+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374216564270080.html 2026-09-01T20:36:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374216591451136.html 2026-07-21T04:50:03+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374216603657216.html 2026-07-21T04:36:10+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374216766743552.html 2026-07-21T04:28:37+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374216782570496.html 2026-07-21T04:27:43+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374263509525504.html 2026-09-01T20:36:35+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374263539688448.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374263558366208.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17457281809163264.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17457281840030720.html 2026-07-21T04:27:28+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17457281860936704.html 2026-09-01T20:36:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17457281900143616.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17457281938695168.html 2026-07-21T04:27:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17457281944577024.html 2026-07-21T04:50:17+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17457281962353664.html 2026-07-21T04:28:02+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/key-considerations-for-dosing-volume-17457281991484416.html 2026-09-01T20:36:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17457282064180224.html 2026-09-01T20:36:46+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17457282069832704.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17457282085479424.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17457282089837568.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17502471646209024.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17502471667196928.html 2026-09-01T20:42:38+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17502471694754816.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-copd-model-17502471807951872.html 2026-09-01T20:36:41+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17502471932077056.html 2025-08-26T05:16:05+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17502493727024128.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/brain-targeted-drug-delivery-17532190352253952.html 2026-09-01T20:36:57+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17532190354367488.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/the-importance-of-administration-volume-17532190360249344.html 2026-07-21T04:27:48+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17532190531167232.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17532190585545728.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17532230476964864.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17532230970778624.html 2026-09-01T20:36:39+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17542767922242560.html 2025-10-07T07:23:56+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17562072657486848.html 2026-09-01T20:37:21+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17648996983415808.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17648997073921024.html 2026-09-01T20:37:06+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17648997470266368.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/rfp-template-for-nhp-studies-17649004753462272.html 2026-09-01T20:36:53+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17649004932719616.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17649013229937664.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17649022270055424.html 2026-07-21T04:36:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-renal-biopsy-17649023423325184.html 2026-09-01T20:36:51+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17649060736558080.html 2026-07-21T04:27:44+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17649090944017408.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17649096905663488.html 2025-12-25T20:25:16+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674686724940800.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674686794015744.html 2026-07-21T04:29:05+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674686801978368.html 2026-09-01T20:37:10+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674687049294848.html 2025-12-25T20:25:37+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674687074919424.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674691405931520.html 2025-12-25T20:32:53+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674691468108800.html 2025-12-25T20:32:56+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674691483427840.html 2026-07-21T04:28:16+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674698387907584.html 2026-01-29T23:28:07+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724393177326592.html 2026-01-29T23:28:05+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724393188107264.html 2026-01-29T23:28:12+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724393206817792.html 2026-01-29T23:28:06+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724393223676928.html 2026-01-29T23:28:07+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724393225888768.html 2026-01-29T23:28:07+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724393269519360.html 2026-01-29T23:28:14+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724393276515328.html 2026-01-29T23:28:11+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724393290703872.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724393579586560.html 2026-01-29T23:28:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724393693668352.html 2026-04-29T10:31:20+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17851041316316160.html 2026-04-29T10:31:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17851041338319872.html 2026-04-29T10:31:35+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/evaluating-dmpk-properties-17851041350624256.html 2026-04-29T10:31:23+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17851041387570176.html 2026-04-29T10:31:45+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17851041400808448.html 2026-04-29T10:31:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17851041416930304.html 2026-04-29T10:31:20+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17851041450533888.html 2026-04-29T10:31:50+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17851041505420288.html 2026-04-29T10:31:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17851041556505600.html 2026-04-29T10:31:48+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17851041557013504.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17851041616913408.html 2026-04-29T10:31:30+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17851041680073728.html 2026-04-29T10:31:30+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17851041787864064.html 2026-04-29T10:31:46+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17851041799775232.html 2026-04-29T10:31:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17851041803396096.html 2026-04-29T10:31:42+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17851042001740800.html 2026-07-21T06:51:20+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888303464997888.html 2026-05-25T18:18:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888303547442176.html 2026-07-21T06:51:30+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888303702713344.html 2026-05-25T18:18:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-models-translational-drug-development-17888303741314048.html 2026-05-25T18:18:44+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888304125912064.html 2026-07-21T06:51:30+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-heart-failure-model-17940778293289984.html 2026-07-21T06:51:27+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17940778479657984.html 2026-07-21T06:51:16+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17940778655228928.html 2026-07-21T06:51:34+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17940778761741312.html 2026-07-21T06:51:24+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17940778914489344.html 2026-07-21T04:28:28+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17940778960167936.html 2026-07-21T06:51:43+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17940779144291328.html 2026-07-21T07:08:35+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17940779959952384.html 2026-07-21T06:51:27+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17940779982709760.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968189947634688.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968190057292800.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968190188692480.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968190422541312.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17973616911459328.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17973616978715648.html 2026-08-23T04:32:01+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/webinar-nhp-behavioratlas-17973617172358144.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17973617204470784.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17973617211106304.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17973617491534848.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17973617641186304.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/behavior-in-rhesus-17983440927990784.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983441040008192.html 2026-08-05T19:24:01+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990296716403712.html 2026-09-01T20:36:57+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993010294236160.html 2026-09-01T20:37:00+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003095074071552.html 2026-09-01T20:37:06+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003096099480576.html 2026-09-01T20:37:31+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18014898944320512.html 2026-08-23T05:46:03+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18014970361308160.html 2026-09-01T20:37:10+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021130159629312.html 2026-09-10T15:42:25+08:00 weekly 0.8 https://mt.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028059374969856.html